Literature DB >> 16650171

Cutaneous phaeohyphomycosis caused by an Itraconazole and Amphoterecin B resistant strain of Veronaeae botryosa.

Yu-Ting Chen1, Hao-Chiung Lin, Chieh-Chen Huang, Yuan-Hsin Lo.   

Abstract

BACKGROUND: Although the dematiaceous fungus Veronaea botryosa is rarely encountered clinically, it can be pathogenic.
METHODS: A patient with a history of diabetes mellitus, coronary artery disease, and Cushing's syndrome had recurrent multifocal, crusted, brownish-red noduloplaques on the right forearm, left upper limb, and right knee. A skin biopsy was obtained for histopathology and fungal cultures.
RESULTS: The histopathology showed brownish hyphae and yeast-like cells scattered in granulomatous infiltrates. Slide cultures revealed erect and straight conidiophores with two-celled cylindrical conidia, which have round tops and truncated bases. The fungus was identified as Veronaea botryosa. The disease slowly progressed despite a 6-month itraconazole regimen (200 mg daily). Subsequent use of Amphoterecin B produced only mild clinical improvements. Susceptibility tests showed resistance to both agents.
CONCLUSIONS: Cutaneous phaeohyphomycosis caused by V. botryosa is extremely rare. Antifungal susceptibility tests are important for choosing the appropriate drug and predicting the clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650171     DOI: 10.1111/j.1365-4632.2006.02619.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

1.  Severe disseminated phaeohyphomycosis in an immunocompetent patient caused by Veronaea botryosa.

Authors:  Alexandro Bonifaz; Mehrnaz Mohammad Davoudi; G S de Hoog; Carmen Padilla-Desgarennes; Denisse Vázquez-González; Gisela Navarrete; Jacques F Meis; Hamid Badali
Journal:  Mycopathologia       Date:  2013-03-08       Impact factor: 2.574

Review 2.  Cutaneous Chromoblastomycosis Caused by Veronaea botryosa in a Patient with Pemphigus Vulgaris and Review of Published Reports.

Authors:  Cheng-Yao Zhu; Yan-Ping Yang; Ping Sheng; Wen Li; Wen-Ming Huang; Yi-Ming Fan
Journal:  Mycopathologia       Date:  2015-03-31       Impact factor: 2.574

Review 3.  Black Molds and Melanized Yeasts Pathogenic to Humans.

Authors:  Anuradha Chowdhary; John Perfect; G Sybren de Hoog
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

Review 4.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  Shared Physiological Traits of Exophiala Species in Cold-Blooded Vertebrates, as Opportunistic Black Yeasts.

Authors:  Mariana Machado Fidelis do Nascimento; G Sybren de Hoog; Renata Rodrigues Gomes; Jason Lee Furuie; Jane Mary Lafayette Gelinski; Mohammad Javad Najafzadeh; Walter Antonio Pereira Boeger; Vania Aparecida Vicente
Journal:  Mycopathologia       Date:  2016-03-30       Impact factor: 2.574

6.  Veronaea botryosa: molecular identification with amplified fragment length polymorphism (AFLP) and in vitro antifungal susceptibility.

Authors:  Hamid Badali; Seyed Amir Yazdanparast; Alexandro Bonifaz; Bita Mousavi; G Sybren de Hoog; Corné H W Klaassen; Jacques F Meis
Journal:  Mycopathologia       Date:  2013-03-06       Impact factor: 2.574

7.  Experimental Infection of Mice with Veronaea botryosa as a Model for Human Phaeohyphomycosis.

Authors:  Rachel D Brownlee; Denise M Imai; Denver J Coleman; Amir Ardeshir; Samah M R Abdelrazek; Esteban Soto
Journal:  Comp Med       Date:  2019-08-06       Impact factor: 0.982

8.  A rare fungal infection: Phaehyphomycosis due to Veronaea botryosa and review of literature.

Authors:  Anne Welfringer; Valérie Vuong; Nicolas Argy; Christian Chochillon; Lydia Deschamps; Guillaume Rollin; Stanislas Harent; Véronique Joly; William Vindrios; Vincent Descamps
Journal:  Med Mycol Case Rep       Date:  2017-02-05

Review 9.  Phaeohyphomycosis in China.

Authors:  Yun He; Hai-Lin Zheng; Huan Mei; Gui-Xia Lv; Wei-da Liu; Xiao-Fang Li
Journal:  Front Cell Infect Microbiol       Date:  2022-06-13       Impact factor: 6.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.